November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Tesla’s Self-Driving Narrative Is Falling Apart
Tesla Stock: The Trump Bump Is Overdone
Tesla’s Upcoming Government Double-Whammy
Nvidia’s Stock Has Huge Potential Upside For 2025
Nvidia: Still Charging Ahead
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Trevi Therapeutics (TRVI) stock forecast for 2025
Updated: December 2, 2024 (01:16)
Sector: HealthcareThe share price of Trevi Therapeutics, Inc. (TRVI) now
50/200 Day Moving Average: $3.053 / $2.931
This figure corresponds to the Average Price over the previous 50/200 days. For Trevi Therapeutics stocks, the 50-day moving average is the resistance level today.
For Trevi Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Trevi Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Trevi Therapeutics stock price in 2025. How much will one Trevi Therapeutics share be worth in 2025? Is it worth taking profit / loss on TRVI stock now or waiting? What are analysts' forecasts for Trevi Therapeutics stock?
We forecast Trevi Therapeutics stock performance using neural networks based on historical data on TRVI stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Trevi Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Trevi Therapeutics analysts is $9.11. Today 200 Day Moving Average is the support level (2.931 $). 50 Day Moving Average is the resistance level (3.053 $).
Historical and forecast chart of Trevi Therapeutics, Inc. stock
The chart below shows the historical price of Trevi Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the TRVI stock price can be found in the table below.
Trevi Therapeutics Inc. is a clinical biopharmaceutical company focused on the development and commercialization of Nalbuphine ER for the treatment of neurologically mediated conditions. The company is developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LD), in patients with Parkinson’s disease. The company is conducting phase 2b/3 clinical trials for nalbuphine ER. The company has also initiated a phase 1b clinical trial in patients with chronic liver disease to evaluate the safety, pharmacokinetics, and antipruritic effect of nalbuphine ER in this population. The Company’s nalbuphine development programs for ER include the Chronic Pruritus Program, the Nodular Pruritus Program, the Chronic Liver Disease Pruritus Program, and the Uremic Pruritus Program.
Trevi Therapeutics (TRVI) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.25 | 2.71 | 3.86 | 29.85 % |
| Feb | 3.88 | 2.99 | 4.67 | 35.88 % |
| Mar | 3.56 | 2.87 | 3.82 | 24.91 % |
| Apr | 3.67 | 3.07 | 4.01 | 23.33 % |
| May | 3.66 | 2.92 | 3.95 | 26.09 % |
| Jun | 3.46 | 2.63 | 3.85 | 31.78 % |
| Jul | 3.09 | 2.78 | 3.45 | 19.34 % |
| Aug | 3.43 | 2.63 | 3.70 | 28.94 % |
| Sep | 3.45 | 3.19 | 3.80 | 16.06 % |
| Oct | 2.65 | 2.25 | 3.06 | 26.28 % |
| Nov | 2.51 | 2.36 | 2.77 | 14.93 % |
| Dec | 2.25 | 1.74 | 2.56 | 32.08 % |
Trevi Therapeutics information and performance
195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT, US
Market capitalization of the Trevi Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TRVI shares in the company outstanding by the market price of one share.
EBITDA of Trevi Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Trevi Therapeutics price target for 2025 by month
Target values for the price of one Trevi Therapeutics share for Jan 2025.
In Jan, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.848% volatility is expected.
Pessimistic target level: 2.71
Optimistic target level: 3.86
Target values for the price of one Trevi Therapeutics share for Feb 2025.
In Feb, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 35.880% volatility is expected.
Pessimistic target level: 2.99
Optimistic target level: 4.67
Target values for the price of one Trevi Therapeutics share for Mar 2025.
In Mar, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.907% volatility is expected.
Pessimistic target level: 2.87
Optimistic target level: 3.82
Target values for the price of one Trevi Therapeutics share for Apr 2025.
In Apr, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.330% volatility is expected.
Pessimistic target level: 3.07
Optimistic target level: 4.01
Target values for the price of one Trevi Therapeutics share for May 2025.
In May, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 26.087% volatility is expected.
Pessimistic target level: 2.92
Optimistic target level: 3.95
Target values for the price of one Trevi Therapeutics share for Jun 2025.
In Jun, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 31.777% volatility is expected.
Pessimistic target level: 2.63
Optimistic target level: 3.85
Target values for the price of one Trevi Therapeutics share for Jul 2025.
In Jul, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 19.337% volatility is expected.
Pessimistic target level: 2.78
Optimistic target level: 3.45
Target values for the price of one Trevi Therapeutics share for Aug 2025.
In Aug, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.943% volatility is expected.
Pessimistic target level: 2.63
Optimistic target level: 3.70
Target values for the price of one Trevi Therapeutics share for Sep 2025.
In Sep, the Positive dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.062% volatility is expected.
Pessimistic target level: 3.19
Optimistic target level: 3.80
Target values for the price of one Trevi Therapeutics share for Oct 2025.
In Oct, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 26.279% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 3.06
Target values for the price of one Trevi Therapeutics share for Nov 2025.
In Nov, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.932% volatility is expected.
Pessimistic target level: 2.36
Optimistic target level: 2.77
Target values for the price of one Trevi Therapeutics share for Dec 2025.
In Dec, the Negative dynamics for Trevi Therapeutics, Inc. shares will prevail with possible monthly volatility of 32.077% volatility is expected.
Pessimistic target level: 1.74
Optimistic target level: 2.56
